DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 10 analysts with an average price target of $40.66. This is a potential upside of $20.57 (102.39%) from yesterday's end of day stock price of $20.09.

Dyne Therapeutics 's activity chart (see below) currently has 74 price targets and 80 ratings on display. The stock rating distribution of DYN is 81.25% BUY and 18.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.54% with an average time for these price targets to be met of 189.46 days.

Highest price target for DYN is $50, Lowest price target is $11, average price target is $33.5.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 14-Nov-2025. First documented stock forecast 12-Oct-2020.

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Currently out of the existing stock ratings of DYN, 26 are a BUY (81.25%), 6 are a HOLD (18.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$17

$-4.9 (-22.37%)

$9

19 days ago
(14-Nov-2025)

8/10 (80%)

$-1.79 (-9.53%)

111

Hold

$11

$-10.9 (-49.77%)

$13

21 days ago
(12-Nov-2025)

1/4 (25%)

$-7.61 (-40.89%)

19

Buy

$30

$8.1 (36.99%)

$23

27 days ago
(06-Nov-2025)

1/6 (16.67%)

$11.79 (64.74%)

90

Buy

$35

$13.1 (59.82%)

$31

3 months 8 days ago
(25-Aug-2025)

0/2 (0%)

$22 (169.23%)

Buy

$36

$14.1 (64.38%)

$41

4 months 2 days ago
(31-Jul-2025)

4/5 (80%)

$26.15 (265.48%)

509

Show more analysts

Please expand the browser size to see the chart

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 189.46 days on average for the stock forecasts to be realized with a an average price target met ratio 46.54

Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Francois Brisebois works at LIFESCI and has 3 price targets and 2 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Steven Seedhouse with highest potential upside - $34.1

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Andreas Argyrides with lowest potential downside - -$10.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?